Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00910624
What this trial is testing

Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 168
Not applicableEnded earlyNCT00843076
What this trial is testing

Impact of Hepatitis C Virus Variability on Steatosis

Who this might be right for
Chronic Hepatitis C
University Hospital, Tours 27
Post-approval studies (Phase 4)Study completedNCT01378104
What this trial is testing

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

Who this might be right for
Sustained Virologic ResponseIL28B Polymorphism
The Catholic University of Korea 178
Testing effectiveness (Phase 2)Study completedNCT03593447
What this trial is testing

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT01965535
What this trial is testing

Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 155
Not applicableStudy completedNCT02068963
What this trial is testing

Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing

Who this might be right for
Hepatitis C
Hologic, Inc. 352
Large-scale testing (Phase 3)Study completedNCT00104052
What this trial is testing

Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 107
Early research (Phase 1)Ended earlyNCT00439959
What this trial is testing

Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

Who this might be right for
Hepatitis C, ChronicHepatitis C
GlaxoSmithKline 48
Testing effectiveness (Phase 2)Ended earlyNCT01384383
What this trial is testing

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 248
Testing effectiveness (Phase 2)Study completedNCT00774397
What this trial is testing

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 719
Post-approval studies (Phase 4)Study completedNCT00948220
What this trial is testing

Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm 26
Not applicableStudy completedNCT02601820
What this trial is testing

The Patient-Reported Outcomes Project of HCV-TARGET

Who this might be right for
Hepatitis C, ChronicLiver Diseases
University of North Carolina, Chapel Hill 1,601
Large-scale testing (Phase 3)Study completedNCT02973503
What this trial is testing

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis

Who this might be right for
Chronic HCV Infection
University Hospital, Clermont-Ferrand 117
Large-scale testing (Phase 3)Study completedNCT00363259
What this trial is testing

Pegintron Induction Therapy in HCV Non-Responders

Who this might be right for
Hepatitis C
Foundation for Liver Research 110
Not applicableStudy completedNCT02851069
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia

Who this might be right for
Chronic Hepatitis C
AbbVie 66
Post-approval studies (Phase 4)Study completedNCT01675427
What this trial is testing

A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 4,766
Not applicableStudy completedNCT00770198
What this trial is testing

Sgp130 in Chronic Human Liver Disease

Who this might be right for
Alcoholic Liver DiseaseChronic Hepatitis C Virus Infection
Erasme University Hospital 129
Testing effectiveness (Phase 2)Study completedNCT01826981
What this trial is testing

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 359
Not applicableStudy completedNCT03884062
What this trial is testing

Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

Who this might be right for
HCC in Chronic HCV Patients With Advanced Liver Fibrosis
Egyptian Liver Hospital 3,000
Post-approval studies (Phase 4)Study completedNCT02864199
What this trial is testing

Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 63
Next Page